Navamedic ASA

NAVA

NO0010205966

Pharmaceuticals

Market Closed - Oslo Bors Other stock markets 11:45:00 2026-03-11 am EDT			5-day change	1st Jan Change
20.30 ^NOK	0.00%		-2.40%	-14.71%

Feb. 12	Navamedic ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Jan. 07	Navamedic ASA Approves Board Appointments	CI

Navamedic EGM elects Morten Jurs as chair of board

Published on 01/07/2026 at 06:42 am EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Navamedic ASA

Feb. 12	Navamedic ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Jan. 07	Navamedic ASA Approves Board Appointments	CI
Jan. 07	Navamedic EGM elects Morten Jurs as chair of board	RE
Dec. 08	Navamedic Names New Finance Chief	MT
Dec. 08	Navamedic appoints Nils Ole Krekling as CFO	RE
Dec. 08	Navamedic ASA Appoints Nils Ole Krekling as Chief Financial Officer, Effective January 1, 2026	CI
Nov. 28	Pharmaceutical Company Navamedic's CFO Steps Down	MT
Nov. 28	Navamedic ASA Announces CFO Changes	CI
Nov. 28	Navamedic says CFO Lars Hjarrand to step down	RE
25-10-28	Navamedic ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-28	Navamedic Q3 adjusted EBITDA NOK 11.3 mln	RE
25-10-28	Navamedic reiterates mid-term ambition of building NOK 1 billion revenue co	RE
25-10-17	Navamedic ASA and Evolsin Medical Sign Exclusive Distribution Agreement for Germany	CI
25-10-17	Navamedic and Evolsin sign exclusive distribution deal for Germany	RE
25-10-17	Navamedic Enlists Evolsin for German Distribution of Antiperspirant Product	MT

Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedicâ€™s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Companyâ€™s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Employees

Sector

Pharmaceuticals

Calendar

Mar. 25 - Earnings release - Annual 2025

More about the company